# $OBJKT Social Sentiment & Intelligence — 2026-08-21 05:00 UTC

> **Asset:** $OBJKT  
> **Momentum Status:** Cooling Down  
> **Timestamp:** 2026-08-21 05:00 UTC (2026-08-21T05:00:00Z)  
> **Canonical URL:** https://cryptitalk.com/2026-08-21-05-00/crypto/OBJKT  
> **Overview Brief:** https://cryptitalk.com/2026-08-21-05-00/crypto.md  

---

## 10-Minute Social Metrics
- **Posts Analyzed:** 2
- **Total Impressions:** 95
- **Likes:** 4
- **Retweets:** 0
- **Comments:** 1

---


## Momentum & Sentiment Analysis
Total Engagement - Comments: 1, Retweets: 0, Likes: 4, Impressions: 95


---

## Cited Community Posts & Evidence


### Post #1 by @Coinmaster100x
> **Author:** [@Coinmaster100x](https://x.com/Coinmaster100x)  
> **Metrics:** 25 likes · 0 retweets · 3 comments · 724 views  


> **Source Link:** [https://x.com/Coinmaster100x/status/2090503756056240452](https://x.com/Coinmaster100x/status/2090503756056240452)  


> **Visual Context:** A cryptocurrency token page for LAYOOO/SOL on the Solana blockchain via PumpSwap, priced at $0.001828 with a market cap of $1.7M, featuring three images of a silverback gorilla dancing.  

> 
> "I saw some kols busy with $layooo 

And yes me tooo LFG"


### Post #2 by @TwinTowerCity
> **Author:** [@TwinTowerCity](https://x.com/TwinTowerCity)  
> **Metrics:** 30 likes · 3 retweets · 8 comments · 1.1K views  


> **Source Link:** [https://x.com/TwinTowerCity/status/2090359156930969892](https://x.com/TwinTowerCity/status/2090359156930969892)  


> **Visual Context:** A digital art poster shows a man in a suit standing before a glowing "XRP" logo and stylized "X" against a futuristic cityscape, with another man in a suit visible from behind facing the scene. The bold "XRP" branding visually reinforces the post's bullish claim that XRP will overtake Ethereum ($ETH) in market position.  

> 
> "XRP will flip ETH

There's nothing the Ethereum maxis can do to stop it
$XRP"




---


## Contributing Accounts

- `@V4wEnko` (https://x.com/V4wEnko)

- `@FereshtehFarma3` (https://x.com/FereshtehFarma3)